ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

TSVT 2seventy bio Inc

4.76
-0.17 (-3.45%)
取引時間後
最終更新日: 06:25:53
15分遅延
名称 銘柄コード 市場 種別
2seventy bio Inc TSVT NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.17 -3.45% 4.76 06:25:53
始値 安値 高値 終値 前日終値
4.93 4.60 5.1299 4.76 4.93
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0320:00BW2seventy bio to Report First Quarter 2024 Financial Results..
2024/4/0522:05BWU.S. FDA Approves Bristol Myers Squibb and 2seventy bio’s..
2024/4/0120:30BW2seventy bio Announces Completion of Oncology and Autoimmune..
2024/3/2106:04BW2seventy bio Announces Appointments of Eli Casdin and..
2024/3/1607:27BWFDA Advisory Committee Votes in Favor of Bristol Myers..
2024/3/0806:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/3/0521:03EDGAR2Form 8-K - Current report
2024/3/0521:00BW2seventy bio Reports Fourth Quarter and Full Year 2023..
2024/3/0121:00BW2seventy bio to Report Fourth Quarter and Full Year 2023..
2024/2/0606:05BW2seventy bio to Participate in Upcoming Investor Conferences
2024/2/0521:02EDGAR2Form 8-K - Current report
2024/2/0520:59BWBristol Myers Squibb and 2seventy bio Share Update on U.S...
2024/2/0306:54EDGAR2Form 8-K/A - Current report: [Amend]
2024/1/3023:25APSBiotech Shares Soar Premarket On Sale Of R&D Assets
2024/1/3021:48EDGAR2Form 8-K - Current report
2024/1/3021:01BW2seventy bio Announces New Strategic Path Forward
2024/1/0606:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
2023/12/1221:25EDGAR2Form 8-K - Current report
2023/12/1209:30BWAbecma Delivers Sustained Progression-Free Survival Versus..
2023/12/1121:00BW2seventy bio to Host Investor Call at 8:00am ET on Tuesday,..
2023/12/0704:00BW2seventy bio Reiterates Commitment to Maximizing Shareholder..
2023/12/0120:49EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
2023/12/0120:46EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
2023/12/0120:43EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
2023/12/0120:40EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
2023/11/2104:31DJNTrending: Bristol Myers Squibb's Blood Cancer Treatment..
2023/11/2022:30DJN2seventy Bio Shares Fall Premarket on Abecma Expansion Delay
2023/11/2021:56DJNFDA Advisory Panel to Meet on Earlier Use of Abecma From..
2023/11/2021:20EDGAR2Form 8-K - Current report
2023/11/2020:59BWBristol Myers Squibb and 2seventy bio Provide Update on U.S...
2023/11/1421:00BW2seventy bio Reports Third Quarter Financial Results and..
2023/11/1021:00BW2seventy bio to Report Third Quarter 2023 Financial Results..
2023/10/2620:05EDGAR2Form 8-K - Current report
2023/9/1405:03EDGAR2Form 8-K - Current report
2023/9/1220:13EDGAR2Form 8-K - Current report
2023/9/1220:00BW2seventy bio Announces Strategic Restructuring to Prioritize..
2023/9/1219:55BW2seventy bio and JW Therapeutics Announce Intent To Expand..
2023/9/0705:54EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/9/0620:00BW2seventy bio to Participate in the 2023 Morgan Stanley..
2023/8/1708:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1707:41EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/8/1509:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1420:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1420:02EDGAR2Form 8-K - Current report
2023/8/1420:00BW2seventy bio Reports Second Quarter Financial Results and..
2023/8/0820:00BW2seventy bio to Report Second Quarter 2023 Financial Results..
2023/8/0205:15BW2seventy bio to Participate in 2023 Wedbush PacGrow..
2023/7/2722:16EDGAR2Form 8-K - Current report
2023/6/1420:00BW2seventy bio Announces Clinical Study Pause of PLAT-08 Trial..
2023/6/0720:00BW2seventy bio to Participate in Upcoming Investor Conference

最近閲覧した銘柄

Delayed Upgrade Clock